Teleflex Inc. Stock
?
Your prediction
Teleflex Inc. Stock
Pros and Cons of Teleflex Inc. in the next few years
Pros
Cons
Performance of Teleflex Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Teleflex Inc. | -1.140% | 0.575% | -14.216% | -49.128% | -14.216% | -60.586% | -71.774% |
| Dexcom Inc. | 0.320% | -0.049% | 7.467% | -26.386% | 7.467% | -37.149% | -22.381% |
| Baxter International | -0.740% | 0.929% | 4.002% | -46.030% | 4.002% | -59.777% | -73.253% |
| Dentsply Sirona Inc. | -1.140% | -2.275% | 9.750% | -44.736% | 9.750% | -69.139% | -76.459% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.When analyzing the financials of Teleflex (US symbol TFX), a seasoned player in the Healthcare Equipment & Supplies sector, a comprehensive assessment reveals a multifaceted picture. Investors looking for viable opportunities may find several reasons to be intrigued, as well as some red flags worth noting. Entering the world of Teleflex means wading through a robust balance sheet, an income statement that tells a tale of profitability, and cash flow metrics revealing inflows and outflows. Let’s delve deeper into each dimension to round out a clearer view.
Firstly, Teleflex has reported a market capitalization of approximately $9.53 billion, suggesting strong investor confidence and a solid foundation for growth. The trailing PE ratio stands at 34.89, while the forward PE is significantly lower at 15.72, indicating that the stock may be undervalued based on future earnings. On the other hand, a glimpse at the profit margin of 9.82% is a testament to the company's profitability, while a revenue TTM (Trailing Twelve Months) figure of roughly $3 billion further solidifies Teleflex’s stature within the healthcare equipment industry.
*Pros: *
Comments
News
Why One Fund Just Bet $4 Million on Teleflex Stock Despite a 42% One-Year Drop
New York City-based Eos Management disclosed a new position in Teleflex (NYSE:TFX) as of December 31, acquiring 30,831 shares in a transaction valued at $3.76 million based on quarter-end pricing.
Buy, Sell, or Hold? Insiders Pile Into These 3 Healthcare Stocks
Insiders are buying healthcare companies in 2025, with a notable increase in Q3.
The stocks on this list provide a value, often a deep value, relative to prior action; the question is whether
